These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

414 related items for PubMed ID: 15882239

  • 1. Heartburn-dominant, uninvestigated dyspepsia: a comparison of 'PPI-start' and 'H2-RA-start' management strategies in primary care--the CADET-HR Study.
    Armstrong D, Veldhuyzen van Zanten SJ, Barkun AN, Chiba N, Thomson AB, Smyth S, Sinclair P, Chakraborty B, White RJ, CADET-HR Study Group.
    Aliment Pharmacol Ther; 2005 May 15; 21(10):1189-202. PubMed ID: 15882239
    [Abstract] [Full Text] [Related]

  • 2. Management of heartburn in a large, randomized, community-based study: comparison of four therapeutic strategies.
    Howden CW, Henning JM, Huang B, Lukasik N, Freston JW.
    Am J Gastroenterol; 2001 Jun 15; 96(6):1704-10. PubMed ID: 11419818
    [Abstract] [Full Text] [Related]

  • 3. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
    Sontag SJ, Kogut DG, Fleischmann R, Campbell DR, Richter J, Robinson M, McFarland M, Sabesin S, Lehman GA, Castell D.
    Am J Gastroenterol; 1997 Mar 15; 92(3):429-37. PubMed ID: 9068463
    [Abstract] [Full Text] [Related]

  • 4. The management of acid-related dyspepsia in general practice: a comparison of an omeprazole versus an antacid-alginate/ranitidine management strategy. Compete Research Group [corrected].
    Mason I, Millar LJ, Sheikh RR, Evans WM, Todd PL, Turbitt ML, Taylor MD.
    Aliment Pharmacol Ther; 1998 Mar 15; 12(3):263-71. PubMed ID: 9570261
    [Abstract] [Full Text] [Related]

  • 5. Step-down from multiple- to single-dose proton pump inhibitors (PPIs): a prospective study of patients with heartburn or acid regurgitation completely relieved with PPIs.
    Inadomi JM, McIntyre L, Bernard L, Fendrick AM.
    Am J Gastroenterol; 2003 Sep 15; 98(9):1940-4. PubMed ID: 14499769
    [Abstract] [Full Text] [Related]

  • 6. The effect of H2-receptor antagonist and proton pump inhibitor on microbial proliferation in the stomach.
    Wang K, Lin HJ, Perng CL, Tseng GY, Yu KW, Chang FY, Lee SD.
    Hepatogastroenterology; 2004 Sep 15; 51(59):1540-3. PubMed ID: 15362796
    [Abstract] [Full Text] [Related]

  • 7. Bedtime administration of lansoprazole does not modify its greater efficacy vs ranitidine in the acute and long-term treatment of duodenal ulcer. Results from a multicentre, randomised, double blind clinical trial.
    Russo A, Dattilo M.
    Ital J Gastroenterol Hepatol; 1997 Aug 15; 29(4):312-9. PubMed ID: 9476183
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A double blind, randomized, placebo-controlled trial of proton pump inhibitor therapy in patients with uninvestigated dyspepsia.
    Rabeneck L, Souchek J, Wristers K, Menke T, Ambriz E, Huang I, Wray N.
    Am J Gastroenterol; 2002 Dec 15; 97(12):3045-51. PubMed ID: 12492188
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Proton pump inhibitors or histamine-2 receptor antagonists for the prevention of recurrences of erosive reflux esophagitis: a cost-effectiveness analysis.
    Harris RA, Kuppermann M, Richter JE.
    Am J Gastroenterol; 1997 Dec 15; 92(12):2179-87. PubMed ID: 9399748
    [Abstract] [Full Text] [Related]

  • 13. [Do proton pump inhibitors after endoscopic control of acute ulcer hemorrhage have an advantage over H2 receptor antagonists?].
    Prassler R, Hendrich H, Barnert J, Richter G, Fleischmann R, Wienbeck M.
    Z Gastroenterol; 1995 Aug 15; 33(8):431-4. PubMed ID: 7483734
    [Abstract] [Full Text] [Related]

  • 14. Rabeprazole versus ranitidine for the treatment of erosive gastroesophageal reflux disease: a double-blind, randomized clinical trial. Raberprazole Study Group.
    Farley A, Wruble LD, Humphries TJ.
    Am J Gastroenterol; 2000 Aug 15; 95(8):1894-9. PubMed ID: 10950032
    [Abstract] [Full Text] [Related]

  • 15. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children.
    Canani RB, Cirillo P, Roggero P, Romano C, Malamisura B, Terrin G, Passariello A, Manguso F, Morelli L, Guarino A, Working Group on Intestinal Infections of the Italian Society of Pediatric Gastroenterology, Hepatology and Nutrition (SIGENP).
    Pediatrics; 2006 May 15; 117(5):e817-20. PubMed ID: 16651285
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cisapride compared with ranitidine in the treatment of functional dyspepsia.
    Carvalhinhos A, Fidalgo P, Freire A, Matos L.
    Eur J Gastroenterol Hepatol; 1995 May 15; 7(5):411-7. PubMed ID: 7614103
    [Abstract] [Full Text] [Related]

  • 18. Lansoprazole compared with ranitidine for the treatment of nonerosive gastroesophageal reflux disease.
    Richter JE, Campbell DR, Kahrilas PJ, Huang B, Fludas C.
    Arch Intern Med; 2000 Jun 26; 160(12):1803-9. PubMed ID: 10871974
    [Abstract] [Full Text] [Related]

  • 19. A randomized trial comparing omeprazole, ranitidine, cisapride, or placebo in helicobacter pylori negative, primary care patients with dyspepsia: the CADET-HN Study.
    Veldhuyzen van Zanten SJ, Chiba N, Armstrong D, Barkun A, Thomson A, Smyth S, Escobedo S, Lee J, Sinclair P.
    Am J Gastroenterol; 2005 Jul 26; 100(7):1477-88. PubMed ID: 15984968
    [Abstract] [Full Text] [Related]

  • 20. Long-term gastroesophageal reflux disease therapy improves reflux symptoms in elderly patients: five-year prospective study in community medicine.
    Miyamoto M, Haruma K, Kuwabara M, Nagano M, Okamoto T, Tanaka M.
    J Gastroenterol Hepatol; 2007 May 26; 22(5):639-44. PubMed ID: 17444849
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.